These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32913556)

  • 1. Molecular profiling of melanoma brain metastases compared to primary cutaneous melanoma and to extracranial metastases.
    In GK; Poorman K; Saul M; O'Day S; Farma JM; Olszanski AJ; Gordon MS; Thomas JS; Eisenberg B; Flaherty L; Weise A; Daveluy S; Gibney G; Atkins MB; Vanderwalde A
    Oncotarget; 2020 Aug; 11(33):3118-3128. PubMed ID: 32913556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-omic profiling reveals discrepant immunogenic properties and a unique tumor microenvironment among melanoma brain metastases.
    In GK; Ribeiro JR; Yin J; Xiu J; Bustos MA; Ito F; Chow F; Zada G; Hwang L; Salama AKS; Park SJ; Moser JC; Darabi S; Domingo-Musibay E; Ascierto ML; Margolin K; Lutzky J; Gibney GT; Atkins MB; Izar B; Hoon DSB; VanderWalde AM
    NPJ Precis Oncol; 2023 Nov; 7(1):120. PubMed ID: 37964004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanoma brain metastases harboring BRAF
    Fang P; Boehling NS; Koay EJ; Bucheit AD; Jakob JA; Settle SH; Brown PD; Davies MA; Sulman EP
    J Neurooncol; 2018 Mar; 137(1):67-75. PubMed ID: 29198052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concordance of somatic mutation profiles (BRAF,NRAS, and TERT) and tumoral PD-L1 in matched primary cutaneous and metastatic melanoma samples.
    Yang S; Leone DA; Biswas A; Deng A; Jukic D; Singh R; Sundram U; Mahalingam M
    Hum Pathol; 2018 Dec; 82():206-214. PubMed ID: 30120967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug delivery to melanoma brain metastases: Can current challenges lead to new opportunities?
    Gampa G; Vaidhyanathan S; Sarkaria JN; Elmquist WF
    Pharmacol Res; 2017 Sep; 123():10-25. PubMed ID: 28634084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence, patterns of progression, and outcomes of preexisting and newly discovered brain metastases during treatment with anti-PD-1 in patients with metastatic melanoma.
    Schvartsman G; Ma J; Bassett RL; Haydu LE; Amaria RN; Hwu P; Wong MK; Hwu WJ; Diab A; Patel SP; Davies MA; Hamerschlak N; Tawbi HA; Glitza Oliva IC
    Cancer; 2019 Dec; 125(23):4193-4202. PubMed ID: 31398264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanoma brain metastases - Interdisciplinary management recommendations 2020.
    Gutzmer R; Vordermark D; Hassel JC; Krex D; Wendl C; Schadendorf D; Sickmann T; Rieken S; Pukrop T; Höller C; Eigentler TK; Meier F
    Cancer Treat Rev; 2020 Sep; 89():102083. PubMed ID: 32736188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COX-2 expression positively correlates with PD-L1 expression in human melanoma cells.
    Botti G; Fratangelo F; Cerrone M; Liguori G; Cantile M; Anniciello AM; Scala S; D'Alterio C; Trimarco C; Ianaro A; Cirino G; Caracò C; Colombino M; Palmieri G; Pepe S; Ascierto PA; Sabbatino F; Scognamiglio G
    J Transl Med; 2017 Feb; 15(1):46. PubMed ID: 28231855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melanoma Brain Metastases Patient-Derived Organoids: An In Vitro Platform for Drug Screening.
    Abedellatif SE; Hosni R; Waha A; Gielen GH; Banat M; Hamed M; Güresir E; Fröhlich A; Sirokay J; Wulf AL; Kristiansen G; Pietsch T; Vatter H; Hölzel M; Schneider M; Toma MI
    Pharmaceutics; 2024 Aug; 16(8):. PubMed ID: 39204387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment patterns and outcomes in BRAF V600E-mutant melanoma patients with brain metastases receiving vemurafenib in the real-world setting.
    Gibney GT; Gauthier G; Ayas C; Galebach P; Wu EQ; Abhyankar S; Reyes C; Guérin A; Yim YM
    Cancer Med; 2015 Aug; 4(8):1205-13. PubMed ID: 25991583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanoma brain metastases have lower T-cell content and microvessel density compared to matched extracranial metastases.
    Weiss SA; Zito C; Tran T; Heishima K; Neumeister V; McGuire J; Adeniran A; Kluger H; Jilaveanu LB
    J Neurooncol; 2021 Mar; 152(1):15-25. PubMed ID: 32974852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Profiling Reveals Unique Immune and Metabolic Features of Melanoma Brain Metastases.
    Fischer GM; Jalali A; Kircher DA; Lee WC; McQuade JL; Haydu LE; Joon AY; Reuben A; de Macedo MP; Carapeto FCL; Yang C; Srivastava A; Ambati CR; Sreekumar A; Hudgens CW; Knighton B; Deng W; Ferguson SD; Tawbi HA; Glitza IC; Gershenwald JE; Vashisht Gopal YN; Hwu P; Huse JT; Wargo JA; Futreal PA; Putluri N; Lazar AJ; DeBerardinis RJ; Marszalek JR; Zhang J; Holmen SL; Tetzlaff MT; Davies MA
    Cancer Discov; 2019 May; 9(5):628-645. PubMed ID: 30787016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct genetic profiles of extracranial and intracranial acral melanoma metastases.
    Sharma G; Lian CG; Lin WM; Amin-Mansour A; Jané-Valbuena J; Garraway L; Bao W; Yoon CH; Ibrahim N
    J Cutan Pathol; 2016 Oct; 43(10):884-91. PubMed ID: 27251777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in the systemic treatment of melanoma brain metastases.
    Glitza Oliva IC; Schvartsman G; Tawbi H
    Ann Oncol; 2018 Jul; 29(7):1509-1520. PubMed ID: 29790899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrative Genomic Analyses of Patient-Matched Intracranial and Extracranial Metastases Reveal a Novel Brain-Specific Landscape of Genetic Variants in Driver Genes of Malignant Melanoma.
    Váraljai R; Horn S; Sucker A; Piercianek D; Schmitt V; Carpinteiro A; Becker KA; Reifenberger J; Roesch A; Felsberg J; Reifenberger G; Sure U; Schadendorf D; Helfrich I
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33578810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microenvironmental Landscape of Human Melanoma Brain Metastases in Response to Immune Checkpoint Inhibition.
    Alvarez-Breckenridge C; Markson SC; Stocking JH; Nayyar N; Lastrapes M; Strickland MR; Kim AE; de Sauvage M; Dahal A; Larson JM; Mora JL; Navia AW; Klein RH; Kuter BM; Gill CM; Bertalan M; Shaw B; Kaplan A; Subramanian M; Jain A; Kumar S; Danish H; White M; Shahid O; Pauken KE; Miller BC; Frederick DT; Hebert C; Shaw M; Martinez-Lage M; Frosch M; Wang N; Gerstner E; Nahed BV; Curry WT; Carter B; Cahill DP; Boland GM; Izar B; Davies MA; Sharpe AH; Suvà ML; Sullivan RJ; Brastianos PK; Carter SL
    Cancer Immunol Res; 2022 Aug; 10(8):996-1012. PubMed ID: 35706413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathologic and gene expression features of metastatic melanomas to the brain.
    Hamilton R; Krauze M; Romkes M; Omolo B; Konstantinopoulos P; Reinhart T; Harasymczuk M; Wang Y; Lin Y; Ferrone S; Whiteside T; Bortoluzzi S; Werley J; Nukui T; Fallert-Junecko B; Kondziolka D; Ibrahim J; Becker D; Kirkwood J; Moschos S
    Cancer; 2013 Aug; 119(15):2737-46. PubMed ID: 23695963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanoma brain metastasis: the impact of stereotactic radiosurgery, BRAF mutational status, and targeted and/or immune-based therapies on treatment outcome.
    Kotecha R; Miller JA; Venur VA; Mohammadi AM; Chao ST; Suh JH; Barnett GH; Murphy ES; Funchain P; Yu JS; Vogelbaum MA; Angelov L; Ahluwalia MS
    J Neurosurg; 2018 Jul; 129(1):50-59. PubMed ID: 28799876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma.
    Doma V; Kárpáti S; Rásó E; Barbai T; Tímár J
    BMC Cancer; 2019 Aug; 19(1):786. PubMed ID: 31391014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological features and clinical outcomes associated with TP53 and BRAF
    Kim DW; Haydu LE; Joon AY; Bassett RL; Siroy AE; Tetzlaff MT; Routbort MJ; Amaria RN; Wargo JA; McQuade JL; Kemnade J; Hwu P; Woodman SE; Roszik J; Kim KB; Gershenwald JE; Lazar AJ; Davies MA
    Cancer; 2017 Apr; 123(8):1372-1381. PubMed ID: 27911979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.